689 | HOW TO OPTIMIZE THE USE OF HIGH‐COST THERAPIES IN DLBCL: A COLLABORATIVE OBSERVATIONAL STUDY BY THE URUGUAYAN LYMPHOMA GROUPVictoria Irigoín, Ana Inés Landoni, V. Lema et al.|Hematological Oncology|2025Cited by 0